Found: 34
Select item for more details and to access through your institution.
89 Zr-Labeled Domain II-Specific scFv-Fc ImmunoPET Probe for Imaging Epidermal Growth Factor Receptor In Vivo.
- Published in:
- Cancers, 2021, v. 13, n. 3, p. 560, doi. 10.3390/cancers13030560
- By:
- Publication type:
- Article
Nimotuzumab Site-Specifically Labeled with 89 Zr and 225 Ac Using SpyTag/SpyCatcher for PET Imaging and Alpha Particle Radioimmunotherapy of Epidermal Growth Factor Receptor Positive Cancers.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3449, doi. 10.3390/cancers12113449
- By:
- Publication type:
- Article
In Vivo Distribution of Polymeric Nanoparticles at the Whole-Body, Tumor, and Cellular Levels.
- Published in:
- Pharmaceutical Research, 2010, v. 27, n. 11, p. 2343, doi. 10.1007/s11095-010-0068-z
- By:
- Publication type:
- Article
Next-generation sequencing-guided identification and reconstruction of antibody CDR combinations from phage selection outputs.
- Published in:
- Nucleic Acids Research, 2019, v. 47, n. 9, p. e50, doi. 10.1093/nar/gkz131
- By:
- Publication type:
- Article
Evaluation of tumor affinity of mono-[<sup>123</sup>I]iodohypericin and mono-[<sup>123</sup>I]iodoprotohypericin in a mouse model with a RIF-1 tumor.
- Published in:
- Contrast Media & Molecular Imaging, 2007, v. 2, n. 3, p. 113, doi. 10.1002/cmmi.136
- By:
- Publication type:
- Article
Cover Feature: Synthetic Modular Antibody Construction by Using the SpyTag/SpyCatcher Protein-Ligase System (ChemBioChem 22/2017).
- Published in:
- ChemBioChem, 2017, v. 18, n. 22, p. 2191, doi. 10.1002/cbic.201700569
- By:
- Publication type:
- Article
A Single-Framework Synthetic Antibody Library Containing a Combination of Canonical and Variable Complementarity-Determining Regions.
- Published in:
- ChemBioChem, 2017, v. 18, n. 22, p. 2247, doi. 10.1002/cbic.201700279
- By:
- Publication type:
- Article
Synthetic Modular Antibody Construction by Using the SpyTag/SpyCatcher Protein-Ligase System.
- Published in:
- ChemBioChem, 2017, v. 18, n. 22, p. 2217, doi. 10.1002/cbic.201700411
- By:
- Publication type:
- Article
Production and Semi-Automated Processing of 89Zr Using a Commercially Available TRASIS MiniAiO Module.
- Published in:
- Molecules, 2020, v. 25, n. 11, p. 2626, doi. 10.3390/molecules25112626
- By:
- Publication type:
- Article
Synthesis and preliminary biological evaluation of a <sup>99m</sup>Tc-labeled hypericin derivative as a necrosis avid imaging agent.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2008, v. 51, n. 1, p. 33, doi. 10.1002/jlcr.1468
- By:
- Publication type:
- Article
Positron Emission Tomographic Imaging of Iodine 124 Anti--Prostate Stem Cell Antigen--Engineered Antibody Fragments in LAPC-9 Tumor--Bearing Severe Combined Immunodeficiency Mice.
- Published in:
- Molecular Imaging, 2013, v. 12, n. 3, p. 191, doi. 10.2310/7290.2012.00033
- By:
- Publication type:
- Article
Biparatopic anti-HER2 drug radioconjugates as breast cancer theranostics.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 153, doi. 10.1038/s41416-023-02272-4
- By:
- Publication type:
- Article
A novel synthetic trivalent single chain variable fragment (tri-scFv) construction platform based on the SpyTag/SpyCatcher protein ligase system.
- Published in:
- BMC Biotechnology, 2018, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12896-018-0466-6
- By:
- Publication type:
- Article
In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 135, n. 1, p. 189, doi. 10.1007/s10549-012-2137-y
- By:
- Publication type:
- Article
Effectiveness of [<sup>67</sup>Cu]Cu-trastuzumab as a theranostic against HER2-positive breast cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 7, p. 2070, doi. 10.1007/s00259-024-06648-3
- By:
- Publication type:
- Article
3p-C-NETA: A versatile and effective chelator for development of Al<sup>18</sup>F-labeled and therapeutic.
- Published in:
- Theranostics, 2022, v. 12, n. 13, p. 5971, doi. 10.7150/thno.75336
- By:
- Publication type:
- Article
Evaluation of nimotuzumab Fab<sub>2</sub> as an optical imaging agent in EGFR positive cancers.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-37873-9
- By:
- Publication type:
- Article
Development of an Epidermal Growth Factor Derivative with EGFR Blocking Activity.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0069325
- By:
- Publication type:
- Article
Estrone-3-Sulphate, a Potential Novel Ligand for Targeting Breast Cancers
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0064069
- By:
- Publication type:
- Article
Gentamicin assay in human serum by solid-phase extraction and capillary electrophoresis.
- Published in:
- Electrophoresis, 2005, v. 26, n. 3, p. 640
- By:
- Publication type:
- Article
Site-Specific Fluorescent Labeling of Antibodies and Diabodies Using SpyTag/SpyCatcher System for In Vivo Optical Imaging.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Development and preclinical evaluation of cixutumumab drug conjugates in a model of insulin growth factor receptor I (IGF-1R) positive cancer.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-75279-z
- By:
- Publication type:
- Article
Effectiveness of <sup>225</sup>Ac-Labeled Anti-EGFR Radioimmunoconjugate in EGFR-Positive Kirsten Rat Sarcoma Viral Oncogene and BRAF Mutant Colorectal Cancer Models.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266204
- By:
- Publication type:
- Article
Efficacy of [<sup>67</sup>Cu]Cu-EB-TATE Theranostic Against Somatostatin Receptor Subtype-2-Positive Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.265997
- By:
- Publication type:
- Article
Efficacy of [<sup>67</sup>Cu]Cu-EB-TATE Theranostic Against Somatostatin Receptor Subtype-2--Positive Neuroendocrine Tumors.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 533, doi. 10.2967/jnumed.123.265997
- By:
- Publication type:
- Article
Effectiveness of <sup>225</sup>Ac-Labeled Anti-EGFR Radioimmunoconjugate in EGFR-Positive Kirsten Rat Sarcoma Viral Oncogene and BRAF Mutant Colorectal Cancer Models.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 3, p. 402, doi. 10.2967/jnumed.123.266204
- By:
- Publication type:
- Article
Radiolabeled iodohypericin as tumor necrosis avid tracer: diagnostic and therapeutic potential.
- Published in:
- International Journal of Cancer, 2012, v. 131, n. 2, p. E129, doi. 10.1002/ijc.26492
- By:
- Publication type:
- Article
Engineering of a Fully Human Anti-MUC-16 Antibody and Evaluation as a PET Imaging Agent.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 12, p. 2824, doi. 10.3390/pharmaceutics14122824
- By:
- Publication type:
- Article
Simultaneous Imaging and Therapy Using Epitope-Specific Anti-Epidermal Growth Factor Receptor (EGFR) Antibody Conjugates.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/pharmaceutics14091917
- By:
- Publication type:
- Article
A <sup>89</sup>Zr-labeled lipoplex nanosystem for image-guided gene delivery: design, evaluation of stability and in vivo behavior.
- Published in:
- International Journal of Nanomedicine, 2018, v. 13, p. 7801, doi. 10.2147/IJN.S179806
- By:
- Publication type:
- Article
Preclinical Evaluation of <sup>111</sup>In-labeled PEGylated Maytansine Nimotuzumab Drug.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.220095
- By:
- Publication type:
- Article
Preclinical Evaluation of <sup>111</sup>In-Labeled PEGylated Maytansine Nimotuzumab Drug Conjugates in EGFR-Positive Cancer Models.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 8, p. 1103, doi. 10.2967/jnumed.118.220095
- By:
- Publication type:
- Article
Concussion/Mild Traumatic Brain Injury (TBI) Induces Brain Insulin Resistance: A Positron Emission Tomography (PET) Scanning Study.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 16, p. 9005, doi. 10.3390/ijms22169005
- By:
- Publication type:
- Article